Dr. Lal PathLabs Ltd
NSE:LALPATHLAB

Watchlist Manager
Dr. Lal PathLabs Ltd Logo
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Watchlist
Price: 2 948.7 INR -0.2% Market Closed
Market Cap: 245.7B INR
Have any thoughts about
Dr. Lal PathLabs Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one LALPATHLAB stock under the Base Case scenario is 3 041.74 INR. Compared to the current market price of 2 948.7 INR, Dr. Lal PathLabs Ltd is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LALPATHLAB Relative Value
Base Case
3 041.74 INR
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.5
P/S
P/S
Price to Sales
10.5
vs History
36
vs Industry
12
Median 3Y
9.9
Median 5Y
10.3
Industry
2.3
Forward
9.7
More Details
61.2
P/E
P/E
Price to Earnings
61.2
vs History
68
vs Industry
5
Median 3Y
67.9
Median 5Y
69.2
Industry
23.2
Forward
55.4
More Details
45.8
P/OCF
P/OCF
Price to OCF
45.8
vs History
44
vs Industry
7
Median 3Y
43.9
Median 5Y
45.9
Industry
14.3
More Details
68.9
P/FCFE
P/FCFE
Price to FCFE
68.9
vs History
66
vs Industry
6
Median 3Y
75.5
Median 5Y
75.8
Industry
20.1
More Details
12.3
P/B
P/B
Price to Book Value
12.3
vs History
50
vs Industry
4
Median 3Y
12.3
Median 5Y
12.8
Industry
2.2
More Details
10
EV/S
EV/S
Enterprise Value to Sales
10
vs History
36
vs Industry
11
Median 3Y
9.5
Median 5Y
10
Industry
2.4
Forward
9.3
More Details
12.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.5
vs History
46
vs Industry
14
Median 3Y
12.4
Median 5Y
12.8
Industry
5
More Details
35.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
35.7
vs History
57
vs Industry
6
Median 3Y
36.4
Median 5Y
39.6
Industry
12.8
Forward
33.2
More Details
45.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.6
vs History
57
vs Industry
6
Median 3Y
47.8
Median 5Y
49.8
Industry
17.2
Forward
42.1
More Details
43.8
EV/OCF
EV/OCF
Enterprise Value to OCF
43.8
vs History
44
vs Industry
8
Median 3Y
42.2
Median 5Y
43.9
Industry
14
More Details
47.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
47.8
vs History
42
vs Industry
9
Median 3Y
42
Median 5Y
45.8
Industry
18.2
More Details
19.2
EV/IC
EV/IC
Enterprise Value to IC
19.2
vs History
52
vs Industry
4
Median 3Y
14.4
Median 5Y
20.1
Industry
1.9
More Details

Multiples Across Competitors

LALPATHLAB Competitors Multiples
Dr. Lal PathLabs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
245.6B INR 10.5 61.2 35.7 45.6
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1

See Also

Summary
LALPATHLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
LALPATHLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LALPATHLAB stock valuation using valuation multiples.
Wall Street Estimates
LALPATHLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LALPATHLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.